Teratogenic Effects of Antileukemic Chemotherapy
- 1 March 1981
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of internal medicine (1960)
- Vol. 141 (4) , 514-515
- https://doi.org/10.1001/archinte.1981.00340040110026
Abstract
The clinical teratogenicity of the newer antileukemic chemotherapeutic agents administered to mothers early in the first trimester of pregnancy is not well defined. Cytarabine and thioguanine were given in identical doses to the same mother during the first trimester of two separate pregnancies. Both pregnancies resulted in viable babies, one with and one without congenital malformations. This case illustrates the highly unpredictable clinical effects on the fetus of chemotherapy early in pregnancy. (Arch Intern Med1981;141:514-515)Keywords
This publication has 6 references indexed in Scilit:
- Consequences of acute myelogenous leukemia in early pregnancyCancer, 1977
- Effects of cytosine arabinoside on in vivo and in vitro mouse limb developmentIn Vitro Cellular & Developmental Biology - Plant, 1977
- Treatment of acute leukemia during pregnancyCancer, 1975
- Studies on induction of polydactyly in rats with cytosine arabinosideDevelopmental Biology, 1975
- Induction of skeletal malformations in organ cultures of mammalian embryonic tissuesNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1974
- Normal Fetus After Cytosine Arabinoside TherapyAnnals of Internal Medicine, 1971